Characteristics and applications of nucleic acid sequence-based amplification (NASBA)

被引:236
作者
Deiman, B [1 ]
van Aarle, P [1 ]
Sillekens, P [1 ]
机构
[1] Organon Teknika BV, NL-5281 RM Boxtel, Netherlands
关键词
NASBA; primer design; isolation; ECL; molecular beacon; RT-PCR;
D O I
10.1385/MB:20:2:163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nucleic acid sequence-based amplification (NASBA) is a sensitive, isothermal, transcription-based amplification system specifically designed for the detection of RNA targets. In some NASBA systems, DNA is also amplified though very inefficiently and only in the absence of the corresponding RNA target or in case of an excess (>1000-fold) of target DNA over RNA. As NASBA is primer-dependent and amplicon detection is based on probe binding, primer and probe design rules are included. An overview of various target nucleic acids that have been amplified successfully using NASBA is presented. For the isolation of nucleic acids prior to NASBA, the "Boom" method, based on the denaturing properties of guanidine isothiocyanate and binding of nucleic acid to silica particles, is preferred. Currently, electro-chemiluminescence (ECL) is recommended for the detection of the amplicon at the end of amplification. In the near future, molecular beacons will be introduced enabling "real-time detection," i.e., amplicon detection during amplification. Quantitative HIV-1 NASBA and detection of up to 48 samples can then be performed in only 90 min.
引用
收藏
页码:163 / 179
页数:17
相关论文
共 80 条
  • [1] Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification
    Aono, T
    Kondo, K
    Miyoshi, H
    Tanaka-Taya, K
    Kondo, M
    Osugi, Y
    Hara, J
    Okada, S
    Yamanishi, K
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05) : 1244 - 1249
  • [2] ARNOLD LJ, 1989, CLIN CHEM, V35, P1588
  • [3] Detection of viable oocysts of Cryptosporidium parvum following nucleic acid sequence based amplification
    Baeumner, AJ
    Humiston, MC
    Montagna, RA
    Durst, RA
    [J]. ANALYTICAL CHEMISTRY, 2001, 73 (06) : 1176 - 1180
  • [4] Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis
    Bestetti, A
    Pierotti, C
    Terreni, M
    Zappa, A
    Vago, L
    Lazzarin, A
    Cinque, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) : 1148 - 1151
  • [5] Blok M J, 1998, Transpl Int, V11 Suppl 1, pS107, DOI 10.1007/s001470050439
  • [6] Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification
    Blok, MJ
    Goossens, VJ
    Vanherle, SJV
    Top, B
    Tacken, N
    Middeldorp, JM
    Christiaans, MHL
    van Hooff, JP
    Bruggeman, CA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (05) : 1341 - 1346
  • [7] RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS
    BOOM, R
    SOL, CJA
    SALIMANS, MMM
    JANSEN, CL
    WERTHEIMVANDILLEN, PME
    VANDERNOORDAA, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) : 495 - 503
  • [8] Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR
    Brink, AATP
    Vervoort, MBHJ
    Middeldorp, JM
    Meijer, CJLM
    van den Brule, AJC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (11) : 3164 - 3169
  • [9] DETECTION OF HIV-1 DISTRIBUTION IN DIFFERENT BLOOD FRACTIONS BY 2 NUCLEIC-ACID AMPLIFICATION ASSAYS
    BRUISTEN, S
    VANGEMEN, B
    KOPPELMAN, M
    RASCH, M
    VANSTRIJP, D
    SCHUKKINK, R
    BEYER, R
    WEIGEL, H
    LENS, P
    HUISMAN, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (03) : 259 - 265
  • [10] Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper
    Cassol, S
    Gill, MJ
    Pilon, R
    Cormier, M
    Voigt, RF
    Willoughby, B
    Forbes, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (11) : 2795 - 2801